BTK阻害剤で治療された患者における皮膚による副作用
Ewa Robak1, Tadeusz Robak2,3
1Department of Dermatology, Medical University of Lodz, 90-647 Łódź, Poland.
Cancers
|February 13, 2026
まとめ
ブルートン・ブリュトン (Bruton Bruton) とは
科学分野:
- 腫瘍学 腫瘍学
- 皮膚科 皮膚科について
- 薬理学 薬理学とは
背景:
- ブルートンのチロシンキナーゼ (BTK) 阻害剤は,CLLやMCLのようなインドレンスのリンパ性悪性腫瘍の治療に不可欠です.
- 一般的な有害事象には,心臓の問題,感染症,皮膚の変化が含まれます.
- 第一世代のBTK阻害剤 (例えばイブルチニブ) は,新しい薬剤よりも高い毒性プロファイルを持っています.
研究 の 目的:
- BTK阻害剤療法に関連する皮膚症状のスペクトルを見直す.
- イブルチニブの皮膚学的毒性を,より新しいBTK阻害剤と比較するために.
- BTK阻害剤に誘発された皮膚反応の臨床および病理学的特徴を要約する.
主な方法:
- PubMed,Web of Science,およびGoogle Scholarを使用して,包括的な文献検索が行われました.
- 英語の記事は優先されました.
- 選択された記事からの引用は,追加の関連する出版物のために見直されました.
主要な成果:
- 皮膚症状は,BTK阻害剤の一般的な副作用であり,特にイブルチニブの場合です.
- 出血,傷, contusionsは,頻繁に皮膚の毒性である.
- 他の皮膚学的問題には,発疹,細胞炎,感染症,,および腫れが含まれます.
結論:
- BTK阻害剤は有効ですが,さまざまな皮膚毒性に関連しています.
- 第2世代および非共性BTK阻害剤は,イブルチニブよりもより好ましい皮膚学的安全性プロファイルを持っているようです.
- これらの皮膚症状を理解し,管理することは,患者のケアにとって極めて重要です.
キーワード:
BTK 阻害剤は,BTK 阻害剤として使用されます.アカラブルチニブ (acalabrutinib) とは血を流している.イブルーチニブとは感染症 感染症粘膜症候群の症状が表れます.中性愛性の皮膚病は,中性愛性の皮膚病である.ピルトブロウチニブ (ピルトブロウチニブ) はピルトブロウチニブ (ピルトブロウチニブ) と呼ばれる.発疹 発疹 発疹 発疹 発疹は皮膚への毒性 皮膚への毒性ザヌブルチニブ (Zanubrutinib) とは ザヌブルチニブ (Zanubrutinib) とは ザヌブルチニブ (Zanubrutinib) とは ザヌブルチニブ (Zanubrutinib) とは関連する概念動画
Local Anesthetics: Adverse Effects
815
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
815
Insulin: Dosing Regimen and Adverse Effects
844
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
844
Skeletal Muscle Relaxants: Adverse Effects
883
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
883
Pharmacodynamics in Geriatric Patients: Effects of Age
241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Buffer Effectiveness
55.6K
Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised.
The buffer capacity is the amount of acid or base that can be added to a given volume...
The buffer capacity is the amount of acid or base that can be added to a given volume...
55.6K


